ArticlePharmacogenomics2016

Rooted in risk: genetic predisposition for low-density lipoprotein cholesterol level associates with diminished low-density lipoprotein cholesterol response to statin treatment.

Roelof Aj Smit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.